{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:08Z","timestamp":1780531208916,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.htct.2023.08.002","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T01:51:45Z","timestamp":1694569905000},"page":"153-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality \u2013cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-6680","authenticated-orcid":false,"given":"Marcia","family":"Garnica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8599-4731","authenticated-orcid":false,"given":"Edvan De Queiroz","family":"Crusoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0933-0562","authenticated-orcid":false,"given":"Glaciano","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7432-3732","authenticated-orcid":false,"given":"Roberto Jos\u00e9 Pessoa","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5652-7798","authenticated-orcid":false,"given":"Karla Richter","family":"Zanella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6671-9710","authenticated-orcid":false,"given":"Abrah\u00e3o Elias","family":"Hallack Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Souza","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Bonamin","family":"Solo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6912-0567","authenticated-orcid":false,"given":"Emmanuella Graciott","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0140-9548","authenticated-orcid":false,"given":"Andre Magalhaes","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Maiolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4327-1957","authenticated-orcid":false,"given":"Vania","family":"Hungria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.htct.2023.08.002_bib0001","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253 multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.htct.2023.08.002_bib0002","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1086\/605664","article-title":"Infections in patients with multiple myeloma in the era of high-dose therapy and novel agents","volume":"49","author":"Nucci","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.htct.2023.08.002_bib0003","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.13532","article-title":"Risks, severity and timing of infections in patients with multiple myeloma: a longitudinal cohort study in the era of immunomodulatory drug therapy","volume":"171","author":"Teh","year":"2015","journal-title":"Br J Haematol"},{"issue":"10241","key":"10.1016\/j.htct.2023.08.002_bib0004","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study","volume":"395","author":"Lee","year":"2020","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.htct.2023.08.002_bib0005","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1038\/s41375-022-01633-x","article-title":"Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period","volume":"36","author":"Neparidze","year":"2022","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.htct.2023.08.002_bib0006","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41408-021-00588-z","article-title":"Impact of COVID-19 in patients with multiple myeloma based on a global data network","volume":"11","author":"Martinez-Lopez","year":"2021","journal-title":"Blood Cancer J"},{"issue":"3","key":"10.1016\/j.htct.2023.08.002_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000523872","article-title":"COVID-19 in patients with hematologic malignancies: clinical manifestations, persistence, and immune response","volume":"145","author":"Gur","year":"2022","journal-title":"Acta Haematol"},{"issue":"3","key":"10.1016\/j.htct.2023.08.002_bib0008","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41375-021-01506-9","article-title":"Inflammation and infection in plasma cell disorders: how pathogens shape the fate of patients","volume":"36","author":"Caro","year":"2022","journal-title":"Leukemia"},{"issue":"7","key":"10.1016\/j.htct.2023.08.002_bib0009","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.clml.2021.02.002","article-title":"Epidemiology and risks of infections in patients with multiple myeloma managed with new generation therapies","volume":"21","author":"Lim","year":"2021","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"10","key":"10.1016\/j.htct.2023.08.002_bib0010","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41408-020-00372-5","article-title":"Multiple myeloma and SARS-CoV-2 infection: clinical characteristics and prognostic factors of inpatient mortality","volume":"10","author":"Mart\u00ednez-L\u00f3pez","year":"2020","journal-title":"Blood Cancer J"},{"issue":"10","key":"10.1016\/j.htct.2023.08.002_bib0011","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1007\/s00277-021-04594-w","article-title":"Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience","volume":"100","author":"Krejci","year":"2021","journal-title":"Ann Hematol"},{"issue":"26","key":"10.1016\/j.htct.2023.08.002_bib0012","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood.2020008150","article-title":"Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set","volume":"136","author":"Chari","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2023.08.002_bib0013","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/ajh.26762","article-title":"Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis","volume":"98","author":"Ho","year":"2023","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.htct.2023.08.002_bib0014","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/16078454.2022.2082725","article-title":"Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: initial results of a UK-wide real-world study","volume":"27","author":"Djebbari","year":"2022","journal-title":"Hematology"},{"issue":"3","key":"10.1016\/j.htct.2023.08.002_bib0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/blood-2009-05-221077","article-title":"Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia","volume":"115","author":"Pal","year":"2010","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.htct.2023.08.002_bib0016","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41408-021-00530-3","article-title":"The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment","volume":"11","author":"Terpos","year":"2021","journal-title":"Blood Cancer J"},{"issue":"13","key":"10.1016\/j.htct.2023.08.002_bib0017","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1200\/JCO.21.02419","article-title":"Risk and outcome of breakthrough COVID-19 infections in vaccinated patients with cancer: real-world evidence from the National COVID Cohort Collaborative","volume":"40","author":"Song","year":"2022","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.htct.2023.08.002_bib0018","doi-asserted-by":"crossref","first-page":"e764","DOI":"10.1097\/HS9.0000000000000764","article-title":"Second booster BNT162b2 restores SARS-CoV-2 humoral response in patients with multiple myeloma, excluding those under anti-BCMA therapy","volume":"6","author":"Ntanasis-Stathopoulos","year":"2022","journal-title":"Hemasphere"},{"issue":"1","key":"10.1016\/j.htct.2023.08.002_bib0019","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s13045-021-01177-0","article-title":"COVID-19 infection in adult patients with hematological malignancies: a European hematology association survey (EPICOVIDEHA)","volume":"14","author":"Pagano","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.htct.2023.08.002_bib0020","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.lungcan.2021.07.002","article-title":"Care disruptions among patients with lung cancer: a COVID-19 and cancer outcomes study","volume":"160","author":"Bhalla","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.htct.2023.08.002_bib0021","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1200\/GO.20.00639","article-title":"Delays and disruptions in cancer health care due to COVID-19 pandemic: systematic review","volume":"7","author":"Riera","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.htct.2023.08.002_bib0022","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1470-2045(20)30388-0","article-title":"The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study","volume":"21","author":"Maringe","year":"2020","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.htct.2023.08.002_bib0023","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S1470-2045(21)00240-0","article-title":"Impact of COVID-19 on cancer care in India: a cohort study","volume":"22","author":"Ranganathan","year":"2021","journal-title":"Lancet Oncol"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923001712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137923001712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T03:08:24Z","timestamp":1719457704000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137923001712"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2531137923001712"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2023.08.002","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 in multiple myeloma patients: frequencies and risk factors for hospitalization, ventilatory support, intensive care admission and mortality \u2013cooperative registry from the Grupo Brasileiro de Mieloma Multiplo (GBRAM)","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2023.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}